Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis
Kovarsky, J.
Texas Medicine 81(9): 35-39
1985
ISSN/ISBN: 0040-4470 PMID: 3931276 Document Number: 250741
Document emailed within 1 workday
Related Documents
Menard, H.A.; Mathieu, J.P.; de Medicis, R.; Lussier, A. 1979: Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results? Journal of Rheumatology 6(2): 156-162Lipsky, P.E. 1989: Mechanisms of action of slow-acting drugs in rheumatoid arthritis Clinical and Experimental Rheumatology 7(Suppl 3): S177-S180
Veys, E.M.; Mielants, H.; Verbruggen, G. 1987: Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study Clinical and Experimental Rheumatology 5(2): 111-116
Kvien, T.K.; Høyeraal, H.M.; Sandstad, B. 1985: Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial Journal of Rheumatology 12(3): 533-539
Scott, I.C.; Kingsley, G.H.; Scott, D.L. 2013: Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis? Clinical and Experimental Rheumatology 31(4 Suppl 78: S4-S8
Van Linthoudt, D.; Gerster, J.-C. 2004: Slow-acting anti-rheumatic agents: recent developments Revue Medicale de la Suisse Romande 124(9): 565-567
Gibofsky, A.; Cannon, G.W.; Harrison, D.J.; Joseph, G.J.; Bitman, B.; Chaudhari, S.; Collier, D.H. 2015: Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2) Clinical and Experimental Rheumatology 33(3): 297-301
Sánchez, T.; Contreras-Yáñez, Iú.; Elías-López, D.; Aguilar Salinas, C.A.; Pascual-Ramos, V. 2014: Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs Clinical and Experimental Rheumatology 32(4): 509-515
Pybus, P.K. 1983: Anti-amoebic drugs in rheumatoid arthritis South African Medical Journal 63(2): 31
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Kurowski, M.; Dunky, A. 1992: Transdermal absorption of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients: I. Diclofenac International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 479
Mesihović, H. 1978: Hepatotoxicity during treatment of juvenile rheumatoid arthritis and rheumatic diseases using salicylates Medicinski Arhiv 32(2): 67-72
Lequesne, M.; Brandt, K.; Bellamy, N.; Moskowitz, R.; Menkes, C.J.; Pelletier, J.P.; Altman, R. 1994: Guidelines for testing slow acting drugs in osteoarthritis Journal of Rheumatology. Supplement 41: 65-71; Discussion 72-3
Olhagen, B. 1985: Non-steroidal anti-inflammatory drugs in the treatment of rheumatic diseases Nordisk Medicin 100(1): 11-13
Dixon, J.S.; Bird, H.A.; Martin, M.F.; McKenna, F.; Wright, V. 1985: Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugs International Journal of Clinical Pharmacology Research 5(1): 25-33
Zorzin, L.; Maira, M.G.; Giobbio, A.; Capone, M. 1985: Use of slow-release sodium diclofenac in patients with rheumatoid arthritis La Clinica Terapeutica 114(2): 105-110
Sigidin, I.A.; Pokryshkin, V.I. 1987: A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis Terapevticheskii Arkhiv 59(4): 73-76
Van Lieshout, A.W.T.; Creemers, M.C.W.; Radstake, T.R.D.J.; Elving, L.D.; van Riel, P.L.C.M. 2008: Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha Journal of Rheumatology 35(5): 938-939
Seriolo, B.; Paolino, S.; Ferrone, C.; Cutolo, M. 2008: Impact of long-term anti-TNF-alpha treatment on insulin resistance in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 26(1): 159-60; author reply 160
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654